11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Ramakrishna H, Li T, He T, Temple J, King MW, Spagnoli A. Tissue engineering a tendon-bone junction with biodegradable braided scaffolds. Biomaterials Research. 23: 11. PMID 31131112 DOI: 10.1186/s40824-019-0160-3  0.36
2019 Li T, Chubinskaya S, Esposito A, Jin X, Tagliafierro L, Loeser R, Hakimiyan AA, Longobardi L, Ozkan H, Spagnoli A. TGF-β type 2 receptor-mediated modulation of the IL-36 family can be therapeutically targeted in osteoarthritis. Science Translational Medicine. 11. PMID 31068441 DOI: 10.1126/scitranslmed.aan2585  0.36
2015 Myers TJ, Longobardi L, Willcockson H, Temple JD, Tagliafierro L, Ye P, Li T, Esposito A, Moats-Staats BM, Spagnoli A. BMP2 Regulation of CXCL12 Cellular, Temporal, and Spatial Expression is Essential During Fracture Repair. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 25967044 DOI: 10.1002/jbmr.2548  0.36
2015 Longobardi L, Li T, Tagliafierro L, Temple JD, Willcockson HH, Ye P, Esposito A, Xu F, Spagnoli A. Synovial joints: from development to homeostasis. Current Osteoporosis Reports. 13: 41-51. PMID 25431159 DOI: 10.1007/s11914-014-0247-7  0.36
2014 Contaldo C, Myers TJ, Zucchini C, Manara MC, Chiodoni C, Colombo MP, Nicoletti G, Lollini PL, Li T, Longobardi L, Scotlandi K, Spagnoli A. Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells. Growth Factors (Chur, Switzerland). 32: 41-52. PMID 24438070 DOI: 10.3109/08977194.2013.870168  0.36
2013 Li T, Longobardi L, Myers TJ, Temple JD, Chandler RL, Ozkan H, Contaldo C, Spagnoli A. Joint TGF-β type II receptor-expressing cells: ontogeny and characterization as joint progenitors. Stem Cells and Development. 22: 1342-59. PMID 23231014 DOI: 10.1089/scd.2012.0207  0.36
2012 Longobardi L, Li T, Myers TJ, O'Rear L, Ozkan H, Li Y, Contaldo C, Spagnoli A. TGF-β type II receptor/MCP-5 axis: at the crossroad between joint and growth plate development. Developmental Cell. 23: 71-81. PMID 22814601 DOI: 10.1016/j.devcel.2012.05.004  0.36
2012 Myers TJ, Yan Y, Granero-Molto F, Weis JA, Longobardi L, Li T, Li Y, Contaldo C, Ozkan H, Ozkhan H, Spagnoli A. Systemically delivered insulin-like growth factor-I enhances mesenchymal stem cell-dependent fracture healing. Growth Factors (Chur, Switzerland). 30: 230-41. PMID 22559791 DOI: 10.3109/08977194.2012.683188  0.36
2010 Myers TJ, Granero-Molto F, Longobardi L, Li T, Yan Y, Spagnoli A. Mesenchymal stem cells at the intersection of cell and gene therapy. Expert Opinion On Biological Therapy. 10: 1663-79. PMID 21058931 DOI: 10.1517/14712598.2010.531257  0.36
2010 Li T, Longobardi L, Granero-Molto F, Myers TJ, Yan Y, Spagnoli A. Use of glycol chitosan modified by 5beta-cholanic acid nanoparticles for the sustained release of proteins during murine embryonic limb skeletogenesis. Journal of Controlled Release : Official Journal of the Controlled Release Society. 144: 101-8. PMID 20116406 DOI: 10.1016/j.jconrel.2010.01.021  0.36
2009 Longobardi L, Granero-Moltó F, O'Rear L, Myers TJ, Li T, Kregor PJ, Spagnoli A. Subcellular localization of IRS-1 in IGF-I-mediated chondrogenic proliferation, differentiation and hypertrophy of bone marrow mesenchymal stem cells. Growth Factors (Chur, Switzerland). 27: 309-20. PMID 19639489 DOI: 10.1080/08977190903138874  0.36
Show low-probability matches.